Cart 0 items $0.00
LIV.52
LIV.52
LIV.52 helps your liver to regain normal functioning after infective hepatitis, alcohol-induced hepatic damage.
Select Doses: 60caps
60caps
1bottle
LIV.52 $19.08
$22.99
$22.99 per bottles
+ Package delivery insurance
+ Next orders 10% discount
ADD TO CART
save: $0.00
60caps
2bottles
LIV.52 $30.50
$37.99
$19.00 per bottles
+ Package delivery insurance
+ Next orders 10% discount
ADD TO CART
save: $7.98
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Country Shipping method Delivery time Price  
Delivery 14-21 days 10$ Tracking# available in 4 days
Delivery 5-9 days 30$ Tracking# available in 2 days
Shipping worldwide Confidentiality and anonymity guarantee
Safe and secure Discreet looking packages
Dispatch orders within 24 hours 100% success delivery
Testimonials Product Description
There is no review for this product at the moment, but you can be the first to add or you can read more in Testimonials Page about related products.
Add Review
Common use

LIV.52 is an ayurvedic remedy to improve liver function. It works by protection of the hepatic parenchyma due to its antioxidant properties. LIV.52 promotes hepatocellular regeneration and restoration of hepatic functions after infective hepatitis, alcohol-induced hepatic damage, or helps people taking allopathic medications to protect liver from their damaging hepatotoxic side effects.



Directions

Take 1 capsule of LIV.52 twice a day, before your meals.



Precautions

As a powerful detoxifying agent it may sometimes cause nausea and exhaustion. Consult your doctor first than to take this medication. Inform your doctor in advance if you are pregnant or breastfeeding before to start this herbal product.



Contraindications

Contraindications have not yet been identified.



Missed dose

Take the missed dose as soon as you remember about it. Do not take extra or doubled dose of this herbal product.



Possible side effects

This product is safe for health. If you need more information get instructions from your doctor.



Storage

Store at room temperature between 59-77 F (15-25 C) away from light and moisture, kids and pets.



Overdose

If you suspect overdose contact your doctor or health care advisor as soon as possible.



More information

Himalaya LIV.52 is a thoroughly blended herb formulation which unites qualities of separate plants to achieve the best results. Each tablet includes such hepatic stimulants as capers (Capparis spinosa), wild chicory (Cichorium intybus), Arjuna (Terminalia arjuna), Yarrow (Achillea millefolium), black nightshade (Solanum nigrum) with antitoxic activity, a digestive and hepatic tonic Cassia occidentalis, and tamarisk (Tamarix gallica) which is a hepatic and digestive stimulant.



Disclaimer

All products presented at this site are not intended to diagnose, treat, cure, or prevent any disease. Don't hesitate to consult your health care practitioner before taking any herbal supplement.
Testimonials
Tiber Snopek, Bratislava, Slovakia
Hello, the service is very good, I have not received my order of a loss of the package (probably) and have sent me another order that I received quickly so it is perfect quality pills I find effective nothing wrong, but how you recommend because I do ...
read more»
Sacha from France
Why I must buy expensive pills while I can get generics on line with delivery to my place and for considerably lower price. I am ready to accept the situation that customer support sometimes can be dull when I want to trace my order.
read more»
News
Keeping livers 'alive' boosts transplant success, trial finds
The alternative to ice involves pumping livers with blood, nutrients and medicines while in a machine.
Thalassaemia gene therapy trial shows 'encouraging' results
The treatment meant some patients stopped needing blood transfusions altogether.
Mental health patients want immediate diagnosis, says report
Research suggests patients would prefer to be told their diagnosis face-to-face.
Migraine: New drug works when others fail, researchers say
The monthly injection could be approved for NHS use by next year, experts hope.
Buy via app in one click